The groundbreaking approach of this peptide represents a exciting development in the care of type 2 diabetes. Distinct from existing medications, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide146188.pages10.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-77465010